Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 18-Sep-24 6:02 PM View:  | Bicara Therapeutics Inc. (BCAX) | 16-Sep-24 | Conversion | 5,122,990 | -- | -- | 100% 0 to 5.12M | |
| 18-Sep-24 6:02 PM View: | Bicara Therapeutics Inc. (BCAX) | 16-Sep-24 | Private Purchase | 1,833,000 | $18.00 | $32,994,000.00 | 36% 5.12M to 6.96M | |
| 23-Aug-24 4:10 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 21-Aug-24 | Disposition (other) | 8,500,000 | -- | -- | (73%) 11.61M to 3.11M | |
| 14-Aug-24 6:05 PM View: | Wave Life Sciences Ltd. (WVE) | 12-Aug-24 | Grant Duplicate | 16,115 | -- | -- | < 1% 18.2M to 18.22M | |
| 13-Aug-24 5:03 PM View: | An2 Therapeutics, Inc. (ANTX) | 09-Aug-24 | Sale | 3,525,090 | $1.08 | $3,807,100.00 | (64%) 5.55M to 2.03M | |
| 24-Jul-24 4:27 PM View: | Artiva Biotherapeutics, Inc. (ARTV) | 22-Jul-24 | Conversion | 1,058,280 | -- | -- | 100% 0 to 1.06M | |
| 24-Jul-24 4:27 PM View: | Artiva Biotherapeutics, Inc. (ARTV) | 22-Jul-24 | Acquisition (other) Duplicate | 461,687 | $10.20 | $4,709,210.00 | 44% 1.06M to 1.52M | |
| 24-Jul-24 4:27 PM View: | Artiva Biotherapeutics, Inc. (ARTV) | 22-Jul-24 | Purchase | 8,333,330 | $12.00 | $100,000,000.00 | 548% 1.52M to 9.85M | |
| 22-Jul-24 5:11 PM View: | Cidara Therapeutics, Inc. (CDTX) | 19-Jul-24 | Conversion | 703,080 | -- | -- | 100% 0 to 703.08K | |
| 01-Jul-24 9:29 PM View: | Eliem Therapeutics, Inc. (ELYM) | 27-Jun-24 | Grant | 5,259,870 | -- | -- | 40% 13.15M to 18.41M | |
| 01-Jul-24 9:29 PM View: | Eliem Therapeutics, Inc. (ELYM) | 27-Jun-24 | Purchase | 13,008,500 | $3.84 | $49,952,800.00 | 71% 18.41M to 31.42M | |
| 28-Jun-24 4:35 PM View: | Janux Therapeutics, Inc. (JANX) | 26-Jun-24 | Grant Duplicate | 2,500 | -- | -- | < 1% 9.17M to 9.17M | |
| 20-Jun-24 5:56 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 17-Jun-24 | Private Purchase | 928,110 | $1.67 | $1,549,940.00 | 11% 8.26M to 9.19M | |
| 14-May-24 9:06 PM View: | Iteos Therapeutics, Inc. (ITOS) | 12-May-24 | Disposition (other) | 900,000 | -- | -- | (20%) 4.42M to 3.52M | |
| 15-Apr-24 4:15 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 11-Apr-24 | Grant | 3,530,000 | $8.50 | $30,005,000.00 | 73% 4.81M to 8.34M | |
| 15-Apr-24 4:15 PM View: | 89bio, Inc. (ETNB) | 11-Apr-24 | Exercise (in-the money or at-the-money) | 1,408,450 | $5.32 | $7,500,000.00 | 11% 12.77M to 14.18M | |
| 04-Apr-24 4:15 PM View: | Boundless Bio, Inc. (BOLD) | 02-Apr-24 | Conversion | 1,868,130 | -- | -- | 100% 0 to 1.87M | |
| 04-Apr-24 4:15 PM View: | Boundless Bio, Inc. (BOLD) | 02-Apr-24 | Purchase | 312,500 | $16.00 | $5,000,000.00 | 17% 1.87M to 2.18M | |
| 27-Mar-24 7:37 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 27-Mar-24 | Purchase | 505,954 | $9.79 | $4,953,290.00 | 5% 10.36M to 10.86M | |
| 29-Mar-24 5:38 PM View: | Nkarta, Inc. (NKTX) | 27-Mar-24 | Private Purchase | 3,000,000 | $10.00 | $30,000,000.00 | 38% 7.81M to 10.81M | |
| 27-Mar-24 7:37 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 26-Mar-24 | Purchase | 457,745 | $9.55 | $4,371,460.00 | 5% 9.9M to 10.36M | |
| 27-Mar-24 7:37 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 25-Mar-24 | Purchase | 437,600 | $9.06 | $3,964,660.00 | 5% 9.46M to 9.9M | |
| 25-Mar-24 8:48 PM View: | Lenz Therapeutics, Inc. (LENZ) | 21-Mar-24 | Grant | 3,245,780 | -- | -- | 515% 629.79K to 3.88M | |
| 25-Mar-24 8:48 PM View: | Lenz Therapeutics, Inc. (LENZ) | 21-Mar-24 | Purchase | 998,009 | $15.03 | $15,000,100.00 | 26% 3.88M to 4.87M | |
| 06-Mar-24 10:00 PM View: | 89bio, Inc. (ETNB) | 04-Mar-24 | Purchase | 1,350,000 | $15.35 | $20,722,500.00 | 12% 11.42M to 12.77M | |
| 20-Feb-24 8:07 PM View: | Icosavax, Inc. (ICVX) | 19-Feb-24 | Disposition (change in control) | 5,969,110 | -- | -- | (100%) 5.97M to 0 | |
| 14-Feb-24 7:49 PM View: | Mineralys Therapeutics, Inc. (MLYS) | 12-Feb-24 | Grant | 1,672,510 | $13.50 | $22,578,900.00 | 53% 3.18M to 4.85M | 5% |
| 13-Feb-24 4:33 PM View: | Pepgen Inc. (PEPG) | 09-Feb-24 | Purchase | 2,557,590 | $10.64 | $27,212,800.00 | 31% 8.13M to 10.69M | |
| 08-Feb-24 5:16 PM View: | Tyra Biosciences, Inc. (TYRA) | 06-Feb-24 | Grant | 3,180,160 | $13.01 | $41,373,800.00 | 44% 7.24M to 10.42M | (6%) |
| 12-Jan-24 5:01 PM View: | Solid Biosciences Inc. (SLDB) | 11-Jan-24 | Purchase | 904,160 | $5.53 | $5,000,000.00 | 27% 3.4M to 4.3M | |
| 13-Dec-23 4:33 PM View: | Wave Life Sciences Ltd. (WVE) | 11-Dec-23 | Purchase | 1,000,000 | $5.00 | $5,000,000.00 | 5% 18.2M to 19.2M | |
| 25-Sep-23 4:30 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 21-Sep-23 | Private Purchase | 2,700,000 | $3.03 | $8,183,530.00 | 18% 15.13M to 17.83M | |
| 31-Aug-23 5:26 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 29-Aug-23 | Purchase | 3,750,000 | $6.20 | $23,250,000.00 | 125% 3.01M to 6.76M | |
| 22-Aug-23 5:01 PM View: | An2 Therapeutics, Inc. (ANTX) | 18-Aug-23 | Private Purchase | 1,777,780 | $9.00 | $16,000,000.00 | 47% 3.77M to 5.55M | |
| 09-Aug-23 5:00 PM View: | Dice Therapeutics, Inc. (DICE) | 09-Aug-23 | Disposition (change in control) | 7,856,610 | -- | -- | (100%) 7.86M to 0 | |
| 25-Jul-23 4:30 PM View: | Acumen Pharmaceuticals, Inc. (ABOS) | 21-Jul-23 | Purchase | 5,161,290 | $7.75 | $40,000,000.00 | 53% 9.77M to 14.93M | |
| 21-Jul-23 4:31 PM View: | Janux Therapeutics, Inc. (JANX) | 19-Jul-23 | Private Purchase | 495,008 | $12.46 | $6,167,800.00 | 6% 8.67M to 9.17M | |
| 07-Jul-23 4:30 PM View: | Black Diamond Therapeutics,... (BDTX) | 05-Jul-23 | Market Purchase | 935,850 | $5.00 | $4,679,250.00 | 36% 2.59M to 3.53M | (10%) |
| 12-Jun-23 8:23 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 08-Jun-23 | Disposition (change in control) | 5,914,250 | -- | -- | (100%) 5.91M to 0 | |
| 30-Mar-23 5:03 PM View: | Dice Therapeutics, Inc. (DICE) | 30-Mar-23 | Purchase | 195,997 | $28.74 | $5,632,950.00 | < 1% 21.34M to 21.54M | |
| 30-Mar-23 5:03 PM View: | Dice Therapeutics, Inc. (DICE) | 29-Mar-23 | Purchase | 66,369 | $29.38 | $1,949,920.00 | < 1% 21.28M to 21.34M | |
| 30-Mar-23 5:03 PM View: | Dice Therapeutics, Inc. (DICE) | 28-Mar-23 | Purchase | 246,779 | $29.24 | $7,215,820.00 | 1% 21.03M to 21.28M | |
| 27-Mar-23 5:01 PM View: | Dice Therapeutics, Inc. (DICE) | 27-Mar-23 | Purchase | 151,132 | $27.48 | $4,153,110.00 | < 1% 19.82M to 19.98M | |
| 27-Mar-23 5:01 PM View: | Dice Therapeutics, Inc. (DICE) | 24-Mar-23 | Purchase | 192,335 | $26.87 | $5,168,040.00 | < 1% 19.63M to 19.82M | |
| 30-Mar-23 5:00 PM View: | 89bio, Inc. (ETNB) | 24-Mar-23 | Purchase | 2,461,540 | $16.25 | $40,000,000.00 | 27% 8.96M to 11.42M | |
| 27-Mar-23 5:01 PM View: | Dice Therapeutics, Inc. (DICE) | 23-Mar-23 | Purchase | 155,089 | $26.67 | $4,136,220.00 | < 1% 19.48M to 19.63M | |
| 27-Feb-23 4:31 PM View: | Enliven Therapeutics, Inc. (ELVN) | 23-Feb-23 | Grant | 1,152,460 | -- | -- | 119% 970.0K to 2.12M | |
| 16-Feb-23 5:04 PM View: | Mineralys Therapeutics, Inc. (MLYS) | 14-Feb-23 | Conversion | 1,928,480 | -- | -- | 100% 0 to 1.93M | |
| 16-Feb-23 5:04 PM View: | Mineralys Therapeutics, Inc. (MLYS) | 14-Feb-23 | Private Purchase | 1,250,000 | $16.00 | $20,000,000.00 | 65% 1.93M to 3.18M | |
| 24-Jan-23 4:30 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 20-Jan-23 | Private Purchase | 1,923,080 | $13.00 | $25,000,000.00 | 20% 9.69M to 11.61M |